[HTML][HTML] Dose modification in biologic therapy for moderate to severe psoriasis: a descriptive analysis in a clinical practice setting
O Baniandrés, VJ Rodriguez-Soria… - Actas Dermo …, 2015 - Elsevier
Introduction In biologic therapy, dose modification in carefully selected patients when
psoriasis is in remission could reduce treatment costs and the risks associated with drug …
psoriasis is in remission could reduce treatment costs and the risks associated with drug …
[引用][C] Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting
O Baniandrés, VJ Rodríguez-Soria… - Actas dermo …, 2015 - produccioncientifica.ucm.es
CONCLUSIONS: Patients with longer-standing disease and longer treatment duration with
the same biologic agent were significantly more likely to be candidates for dose reduction …
the same biologic agent were significantly more likely to be candidates for dose reduction …
Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting
O Baniandrés, VJ Rodríguez-Soria… - Actas dermo …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction In biologic therapy, dose modification in carefully selected patients when
psoriasis is in remission could reduce treatment costs and the risks associated with drug …
psoriasis is in remission could reduce treatment costs and the risks associated with drug …
Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
O Baniandrés, VJ Rodríguez-Soria… - Actas Dermo …, 2015 - europepmc.org
Results At the time of the study, 42.9% of the patients were receiving the standard dose,
50% were on a reduced dose, and 7.1% were on an escalated regimen. The agent with …
50% were on a reduced dose, and 7.1% were on an escalated regimen. The agent with …
Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting
O Baniandrés, VJ Rodríguez-Soria… - Actas Dermo …, 2015 - infona.pl
In biologic therapy, dose modification in carefully selected patients when psoriasis is in
remission could reduce treatment costs and the risks associated with drug exposure …
remission could reduce treatment costs and the risks associated with drug exposure …